FDA & Prescription Drugs

• FDA panel votes to eliminate Vicodin, Percocet

  Brandy Miller | April 30, 2012 4:35 PM | 0 CommentsHouston, TX

  Government experts called for sweeping safety restrictions on the most widely used painkiller, including reducing the maximum dose of Tylenol and eliminating prescription drugs such as Vicodin...

• Actos Risk How It Affects The Nations.

  Brandy Miller | April 25, 2012 5:01 PM | 0 CommentsHouston, TX

  In accordance to the 2011 National Diabetes release on January 26, 2011, 25.8 million children and adults in the United States alone are diagnoses with diabetes. Type 2- diabetes is...

• Lawsuit Claims Actos Maker Hid Adverse Effects

  Scott Kappes | March 13, 2012 2:06 PM | 1 CommentHouston, TX

  A whistle-blower claims that Takeda Pharmacueticals failed to provide accurate reports about hundreds of congestive heart failures associated with the its diabetes medication Actos. The...

• Another Death Increases Pradaxa Hemorrhage Concerns

  Scott Kappes | March 08, 2012 2:38 PM | 0 CommentsHouston, TX

  The recent death of an elderly man who suffered a massive brain hemorrhage after a routine fall has added more fuel to the swirling controversy surrounding the blood clot preventing drug...

• Some Anti-Psychotics are Safer than Others

  Scott Kappes | February 27, 2012 3:07 PM | 2 CommentsHouston, TX

  For years we have known that anti-psychotic medications can increase mortality risks in some patients with dementia, but a new study now suggests that the risks can drastically change...

• EMA Reviewing MS Drug Gilenya after 11 Deaths

  Scott Kappes | January 23, 2012 1:14 PM | 0 CommentsHouston, TX

  Last month the FDA launched a probe to investigate the safety of Novartis’ multiple sclerosis drug Gilenya, after a patient died unexpectedly within 24 hours of taking the first dose...

• Johnson & Johnson has Agreed to Pay $158M in Texas Off-Label Marketing Case

  Scott Kappes | January 20, 2012 2:32 PM | 1 CommentHouston, TX

  Pharmaceutical giant Johnson & Johnson has agreed to a settlement that will have the New Jersery based drug manufacturer paying out $158 million to the state of Texas. Texas officials...

• New Study Reaffirms Hypertension and Antidepressant Link in Newborns

  Scott Kappes | January 13, 2012 1:56 PM | 0 CommentsHouston, TX

  A new study published in yesterday’s British Medicine Journal has again linked the use of certain antidepressant medications by pregnant mothers to an increased risk of pulmonary...

• Ex-FDA Head says Bayer hid Yasmin Blood Clot Risks

  Scott Kappes | December 14, 2011 3:35 PM | 0 CommentsHouston, TX

  According to a report, the ex-head of the FDA, David Kessler, claims that despite having documented evidence that serious side effects like blood clots and deep vein thrombosis (DVT) were...

• Third Levaquin Tendon Rupture Trial Ends with Defense Verdict

  Scott Kappes | October 17, 2011 3:49 PM | 0 CommentsHouston, TX

  The third of more than 2500 pending lawsuits related to tendon injuries suffered as a result of taking the antibiotic Levaquin has ended with a verdict for the defendants. A New Jersey jury came...